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Summary
Background: Articular cartilage is a unique tissue in that it is avascular with its nutrition and oxygen supply being dependent on the diffusion
of solutes through the synovial fluid and to and from the subchondral bone. The oxygen levels in articular cartilage, therefore, are assumed
to be low. Oxygen is an important modulator of gene expression and this regulation occurs largely through the activation of the transcriptional
complex hypoxia-inducible factor-1 (HIF-1). However, little is known about how articular cartilage regulates genes in response to O2 tension
and whether this regulation occurs through HIF-1.
Aim: The aim of this study was to investigate the expression profile of HIF-1 in normal and osteoarthritic (OA) chondrocytes under normoxic
and hypoxic conditions, and in response to treatment with tumor necrosis factor alpha (TNF).
Methods: Articular chondrocytes from human normal and OA knee cartilage were isolated and cultured in suspension under normoxic (21%
O2) or hypoxic conditions (1% O2). Chondrocytes were also treated with TNF- under normoxic conditions. Nuclear extracts and total RNA
were prepared and HIF-1 protein and mRNA levels were assayed by immunoblotting and Northern hybridization. Localization of HIF-1 by
immunofluorescence was performed on frozen sections of cartilage tissue by confocal microscopy.
Results: HIF-1 expression was detectable in human normal and OA chondrocytes and cartilage by Northern analysis, immunoblotting and
immunofluorescence under normoxic conditions. Culture of OA or normal chondrocytes under hypoxic conditions for up to 16 h resulted in
a modest stabilization and/or increase of HIF-1 expression. Treatment of articular chondrocytes with TNF resulted in an increase in HIF-1
protein steady state levels under normoxic conditions. The increase in HIF-1 expression induced by TNF was partially blocked by
pretreatment of the chondrocytes with inhibitors of NFB or p38 MAP kinase. We also observed the expression of HIF-2 mRNA in human
chondrocytes.
Conclusion: HIF-1 is expressed in human normal and OA articular chondrocytes cultured under normoxic conditions. HIF-1 can be further
induced or stabilized in articular chondrocytes by hypoxia or by treatment with TNF. The relatively high constitutive expression of HIF-1
by chondrocytes may be an important adaptation to survival in the avascular-hypoxic environment of cartilage. Modulation of HIF-1 levels
by TNF- may have important implications for chondrocyte metabolism during degenerative joint disease. In addition, we detected for the first
time the expression of HIF-2 mRNA in chondrocytes.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
It is well known that articular cartilage is an avascular tissue
that derives its nutrition and oxygen supply by diffusion
from the synovial fluid and the subchondral bone. It has
been estimated that the chondrocytes at the articular sur-
face are exposed to approximately 6 to 10% O2 whereas
the chondrocytes in the deepest layers of the articular
cartilage may have access to only 1 to 6% O2 or less1–7.
Other studies have shown that articular chondrocytes
derive up to 75% of their ATP requirement from anaerobic
glycolysis, underlining their adaptation to a low O2 environ-
ment8,9. However, the mechanisms by which articular
chondrocytes regulate genes that are sensitive to O2 levels
under normal and pathological conditions remain poorly
understood.
The role of oxygen as an important modulator of gene
expression is well recognized and extensive evidence
implicates hypoxia-inducible factor (HIF-1) as the primary
gene regulatory factor that responds to variations in O2
levels10. HIF-1 is a heterodimer consisting of two different
subunits, HIF-1 and HIF-1, (also known as ARNT- aryl-
hydrocarbon receptor nuclear translocator) that are mem-
bers of the bHLH-PAS (basic helix-loop-helix-PER-ARNT-
SIM) family of transcription factors11,12. HIF-1 is con-
stitutively expressed, whereas exposure to hypoxia inhibits
the rapid proteosome-mediated degradation of HIF-1,
thereby increasing the steady-state levels of HIF-1 protein
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in the cell13,14. Once HIF-1 protein levels are stabilized, it
can translocate to the nucleus, dimerize with HIF-1 and
bind to regulatory regions of hypoxia-responsive genes
through the hypoxia response element (HRE) leading to
their transcriptional activation15,16. Genes that are regu-
lated by HIF-1 in response to O2 tension include those
encoding growth and angiogenic factors, glycolytic en-
zymes and glucose transporters (17 and refs. therein).
Indeed, it has been demonstrated that mammalian cells
lacking HIF-1 show decreased growth rates during both
hypoxia and normoxia, as well as decreased levels of
mRNA for multiple glycolytic enzymes and glucose trans-
porters18. The diminishing glycolytic capacity results in
lowered free ATP levels in hypoxic cells and, therefore,
HIF-1 activation is an important control mechanism of the
metabolic state during hypoxia19. It has become increas-
ingly clear, however, that HIF-1 levels are regulated by
factors other than O2 levels. Recent work has shown that
growth factors, such as IGF-1 and 2, and cytokines, such
as IL-1 and TNF, can influence the levels of HIF-1
protein and HIF-1 DNA-binding activity within the cell20.
Interestingly, both cytokines and growth factors generally
cause an induction of HIF-1 levels or HIF-1 DNA-binding
activity, albeit most likely through different mechanisms.
Indeed, recent evidence indicates that IGF-1 acts to
increase HIF-1 levels by influencing the translation of
HIF-1 mRNA whereas TNF- may regulate HIF-1 by
increasing its stability and nuclear translocation in a NF-B
dependent manner21–24.
Since it is assumed that articular cartilage is normally
hypoxic as compared to vascularized tissues, there has
been investigation into the effect of low O2 tension on the
growth and phenotype of articular cartilage in vitro. These
studies have substantiated the notion that chondrocytes
are well adapted to an hypoxic environment and that
culture in a low O2 tension environment may be beneficial
for maintenance of the chondrocyte-specific phenotype
in vitro8,25. Indeed, culture of articular chondrocytes in a
low O2 environment has been shown to augment
chondrocyte-specific gene expression and speed recovery
of the differentiated phenotype following loss of their
chondrocyte-specific phenotype during monolayer
culture26–29. It has been postulated that during degener-
ative joint diseases such as OA, the O2 gradient across
articular cartilage may be altered due to cartilage thinning
and erosion, changes in extracellular matrix composition,
and the development of cartilage fissures5,26. However,
very little is known about how articular chondrocytes regu-
late gene expression in response to varying O2 concen-
trations under normal and pathological situations, and to
what extent HIF-1 is involved in the response. We recently
reported that HIF-1 mRNA levels are down-regulated in
de-differentiated chondrocytes as compared to differ-
entiated chondrocytes and we have also detected HIF-1
transcripts in both human adult normal and OA chondro-
cytes30. The aim of the present study was to investigate the
expression profile of HIF-1 in normal and OA human
chondrocytes under normoxic and hypoxic conditions and
in response to treatment with TNF- and to investigate the
localization of HIF-1 in human articular cartilage.
Materials and methods
ISOLATION AND CULTURE OF HUMAN NORMAL AND OA
CHONDROCYTES
Human chondrocytes were obtained from the femoral
condyles and tibial plateaus of patients with OA that
underwent knee-joint replacement surgery at Thomas
Jefferson University Hospital and from normal donors at
autopsy through the National Disease Research Inter-
change or the Cooperative Human Tissue Network follow-
ing procedures approved by the Institutional Review Board.
The chondrocytes were isolated from all remaining carti-
lage tissue as previously described31. Briefly, to remove
adherent fibrous tissues, the cartilage was incubated in
Hanks’ medium containing trypsin and bacterial colla-
genase (2 mg/ml each) for 1 h at 37°C. The medium was
discarded and the tissue fragments minced and digested
overnight at 37°C in Dulbecco’s minimum essential
medium (DMEM) with 4.5 g/l glucose containing 10% fetal
bovine serum and 0.5 mg/ml bacterial collagenase. The
released cells were filtered through a 70 µm nylon cell
strainer and were collected by centrifugation at 250×g for
5 min and washed four times with collagenase-free
medium. Isolated chondrocytes were immediately frozen in
freezing media (90% FBS, 10% DMSO) and stored for
future experiments. For experiments involving suspension
cultured chondrocytes, which preserves the differentiated
phenotype, cells were thawed and plated into suspension
in 6-well ultralow attachment plates (Corning, Acton, MA) at
a density of 1×106/ml. The cells were allowed to recover for
48 h at which time they were utilized for experiments.
Chondrocytes utilized for experiments in suspension cul-
ture were not cultured in monolayer before use. For exper-
iments involving monolayer cultures of chondrocytes, cells
were thawed and plated into 162 cm2 plastic tissue culture
flasks at a density of 30 000/cm2 and cultured for 30 days
through three passages. All cultures were grown in DMEM
containing 10% FBS, 2 mM glutamine, 1% vitamin supple-
ments, 100 units/ml penicillin and 100 µg/ml streptomycin.
Amphotericin B and ascorbic acid were avoided because
they can interfere with HIF-1 expression32. For normoxic
conditions, cells were maintained at 37°C in 5% CO2 and
95% air (21% O2). To subject the cells to hypoxia, cultures
were placed in a modular incubator chamber (Billups-
Rothenburg, Del Mar, CA) that had been flushed with a
mixture of 1% O2, 5% CO2 and 94% N2. Hypoxic conditions
within the chamber were verified with a YSI model 55
dissolved oxygen meter (YSI Inc., Yellow Springs, OH).
TNF was purchased from Pierce Endogen (Rockford,
IL). For TNF treatment, chondrocytes were cultured for
18 h in media containing 0.5% serum followed by a 4 h
treatment with 10ng/ml TNF- in media containing 0.5%
serum.
RNA ISOLATION AND NORTHERN HYBRIDIZATION ANALYSIS
Total cellular RNA was isolated from human HTB chon-
drosarcoma cells and human normal and OA chondrocytes
utilizing the Trizol reagent (Life Technologies, Rockville,
MD) according to the manufacturer’s specifications. HTB
chondrosarcoma poly-A+ RNA was obtained using the
Oligotex mRNA kit from Qiagen (Valencia, CA). cDNA for
human HIF-1, -2 and-1 for use as probes in Northern
analyses were obtained from HTB poly-A+ RNA by reverse
transcriptase-polymerase chain reaction (RT-PCR). First
strand cDNA was generated using Superscript II reverse
transcriptase (Life Technologies) and oligo-dT as a primer.
PCR was performed with the Expand High Fidelity Polym-
erase System (Roche Diagnostics, Indianapolis, IN) and
PCR products were cloned into the pCR-Blunt vector
(Invitrogen, Carlsbad, CA). The following primer pairs
were used: HIF-1, ACCATGCCCCAGATTCAGGA (for-
ward) and ATCAGTGGTGGCAGTGGTAGTGGT (reverse);
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HIF-2, GGGGATCAGCGCACAGAGTT (forward) and TGG
GCTGACGACAGGCTGTA (reverse); HIF-1, GGTCCCAC
AGCTAATTTACC (forward) and ATCTGTCCTGCAGAAG
CTGA (reverse). The PCR conditions were an initial
denaturation of 94oC for 2 min followed by 32 cycles of
94oC for 30 s, 63oC for 30 s and 72oC for 1 min and then a
finishing step of 72oC for 5 min. The identity of the cDNA
clones was verified by sequencing with an ABI automatic
sequencer (Perkin-Elmer, Norwalk, CT).
For Northern analyses, 8 µg of total RNA from two
different normal and two different OA human chondrocyte
isolates was electrophoresed on 1% agarose-
formaldehyde gels and transferred to Hybond-N+ or XL
membranes (Amersham Pharmacia Biotech, Piscataway,
NJ) as described previously30. The blots were hybridized in
5× SSC, 2× Denhardt’s solution, 50% formamide, 0.1–
0.5% SDS and 0.1 mg/ml denatured salmon sperm DNA at
42°C for 18 h with 32P-labeled cDNA probes. The blots
were washed to a stringency of 0.2× SSC/0.1% SDS at
65°C for 30 min and then exposed to a phosphor imaging
cassette. A cDNA probe for human GAPDH was included in
the hybridizations as a control for variation in loading of the
gels.
PREPARATION OF NUCLEAR EXTRACTS AND WESTERN ANALYSES
Nuclear extracts were prepared from isolated chondro-
cytes according to the method of Dignam et al.33, using the
CellLytic NuCLEAR extraction kit (Sigma-Aldrich, St. Louis,
MO). Briefly, cells were placed in hypotonic buffer (10 mM
HEPES [pH 7.9], 1.5 mM MgCl2, 10 mM KCl, and 0.5 mM
DTT) and incubated on ice for 15 min. Igeapal CA-630 was
added to a final concentration of 0.6% and the mixture was
vortexed vigorously for 10 s. Nuclei were recovered by
centrifugation at 3300×g for 30 s at 4°C and extracted in
buffer containing 20 mM HEPES pH 7.9, 0.42 M NaCl, 25%
glycerol, 1.5 mM MgC12, 0.2 mM EDTA, and 0.5 mM DTT
for 30 min at 4°C by gentle shaking. The extract was
centrifuged for 15 min at 25 000×g, and the supernatant
was then frozen at −70oC. All buffers contained a protease
inhibitor mixture (2 mM 4-(2-aminoethyl) benzenesulfonyl-
fluoride, 1.4 pM trans-epoxysuccinyl-L-leucylamido [4-gua-
nidinobutane], 130 pM bestatin, 1 µM leupeptin, 0.3 pM
aprotinin, Sigma-Aldrich) and 2.6 µM calpain inhibitor I
(Calbiochem, San Diego CA).
For Western analysis, 35–50 µg of chondrocyte nuclear
extract was separated on 8% SDS-polyacrylamide gels and
transferred to Hybond-P membranes (Amersham Pharma-
cia Biotech) in 20 mM Tris, 150 mM glycine and 20%
methanol at 40V for 18 h at 4°C. The membranes were
blocked with PBS wash solution containing 5% nonfat milk
and 0.1% Tween 20 (PBSMT). The primary antibody was a
mouse monoclonal anti-HIF-1 antibody (1/250 dilution,
Transduction Laboratories, Lexington, KY) and the second-
ary antibody was a horse anti-mouse IgG-horseradish
peroxidase conjugate (1/2000 dilution, Vector Laboratories,
Burlingame, CA). The membranes were washed 3 times
(1×15 min and 2×10 min) each between antibody incuba-
tions with PBMST. The blots were developed using the ECL
detection kit (Amersham Pharmacia Biotech).
IMMUNOFLUORESCENCE
Slices of normal and OA cartilage from one donor each
were frozen in liquid N2-cooled 2-methylbutane in OCT
freezing medium (Miles, Elkhart, IN) and maintained at
-80°C. The immunofluorescence was carried out by the
method of Schipani et al34. Frozen sections (6 microns)
were fixed in acetone for 20 min at –20°C and then
permeabilized with 0.1% Triton X-100 in 0.1% sodium
citrate. After blocking with 1.5% normal goat serum in
PBS/1% BSA, sections were incubated with a rabbit poly-
clonal anti-HIF-1 antibody (H206, Santa Cruz Biotech-
nology, Santa Cruz, CA) at a dilution of 1:100. Binding
was revealed by employing a biotinylated goat anti-rabbit
IgG (1/250 dilution, Pierce, Rockford, IL), and the detection
carried out with streptavidin-Texas red (1/300 dilution,
Pierce). Images were obtained with an Olympus inverted
confocal microscope.
Results
EXPRESSION OF HIF-1, -2 AND 1 mRNA IN HUMAN
CHONDROCYTES
We recently reported the detection of HIF-1 mRNA
expression in human OA cartilage by RT-PCR. Here, we
confirmed and extended those results by performing North-
ern analyses on RNA extracted from human normal and OA
chondrocytes which had been cultured under normoxic
conditions employing cDNA probes for HIF-1, -2 and -1.
Fig. 1 shows that HIF-1 mRNA was readily detected
in normoxic human normal and OA chondrocytes. We
also detected mRNA for HIF-1 which is constitutively
expressed by numerous cell types. Interestingly, mRNA for
HIF-2 was also detected in both normal and OA chondro-
cytes. HIF-2 expression has previously been detected in
developing kidney and lung, and in vascular endothelial
and osteoblastic cells35,36.
DIFFERENTIATED CHONDROCYTES EXPRESS HIF-1 PROTEIN
UNDER NORMOXIC CONDITIONS
Normally, HIF-1 protein levels are undetectable in cells
under normoxic conditions, however, the expression profile
of HIF-1 in articular cartilage, an avascular-hypoxic tissue,
is not known. In order to determine whether articular
chondrocytes express HIF-1 protein under normoxic con-
ditions, nuclear extracts were prepared from human OA
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Fig. 1. Northern analysis of HIF-1, HIF-2 and HIF-1 mRNA
expression in human OA and normal chondrocytes cultured under
normoxic conditions. Total cellular RNA (8 µg) prepared from
normal (N) and osteoarthritis (OA) chondrocytes that had been
cultured for 48 h under normoxic conditions was electrophoresed
on a 1% agarose-formaldehyde gel, transferred to Hybond-XL
membrane and hybridized with cDNA for HIF-1, HIF-2, HIF-1
and GAPDH. Lanes 1 and 2, normal chondrocytes; lanes 3 and 4,
OA chondrocytes.
338 I. B. Coimbra et al.: HIF-1 expression in human articular chondrocytes
chondrocytes cultured either in suspension (differ-
entiated) or as monolayers in plastic tissue culture flasks
(de-differentiated) and then Western blot analysis was
performed with anti-HIF-1 antibodies. Surprisingly, we
detected a strong HIF-1 signal in differentiated articular
chondrocytes cultured in suspension under normoxic con-
ditions (Fig. 2A). In agreement with our earlier studies in
which we observed a down-regulation of HIF-1 mRNA in
de-differentiated chondrocytes30, we could not detect
HIF-1 protein by Western analysis in de-differentiated
human OA chondrocytes (Fig. 2A). In order to verify our
observation of HIF-1 expression in chondrocytes under
normoxic conditions, we performed Western analysis on
nuclear extracts from chondrocytes isolated from six other
donors; four from patients with OA and two normal donor
samples. We detected HIF-1 expression in all six samples
as can be seen in the Western analyses shown in Fig. 2B.
INDUCTION OF HIF-1 IN ARTICULAR CHONDROCYTES BY HYPOXIA
We next determined whether hypoxia would induce
higher levels of HIF-1 in OA or normal articular chondro-
cytes in culture. Utilizing a hypoxic incubation chamber we
first determined the dissolved O2 levels in cell culture
media after purging the chamber with a mixture of 94% N2,
5% CO2 and 1% O2. As can be seen in Fig. 3A, hypoxic
conditions in the media were achieved within 1 h of purging
and remained stable for up to 16 h. This was further verified
by subjecting HEP-3B cells to a 4 h hypoxic treatment in
the chamber followed by immunofluorescence to detect
HIF-1 expression (Fig. 3B). OA or normal articular
chondrocytes that were cultured in suspension were sub-
jected to a hypoxic treatment of 1% O2 for 0, 4, 8 or 16 h.
Nuclear extracts were then prepared and HIF-1 protein
levels were determined by Western analysis. As can be
seen in Fig. 3C–E, exposure of either normal or OA
articular chondrocytes to hypoxic conditions for increasing
lengths of time resulted in a modest increase in the HIF-1
signal. We also observed that the HIF-1 bands became
consolidated into a single higher molecular weight band
during the hypoxic treatment. Whether this is due to a
decrease in degradation, an increase in phosphorylation, or
both, remains to be determined. Finally, as a control for
overall HIF-1 induction, we performed an induction exper-
iment with the hypoxia mimic CoCl2. As can be seen in
Fig. 3F, HIF-1 is readily inducible in normal human articu-
lar chondrocytes upon a 4 h treatment with 100 µM CoCl2.
LOCALIZATION OF HIF-1 IN ARTICULAR CARTILAGE
In order to verify the results obtained with the chondro-
cyte cell cultures, we next performed immunofluorescence
analysis for HIF-1 expression on frozen sections of OA
and normal cartilage. The sections were probed with a
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Fig. 2. (A) Effect of chondrocyte dedifferentiation on HIF-1 protein expression. Nuclear extract (35 µg) prepared from either differentiated
OA chondrocytes grown in suspension (S) or dedifferentiated chondrocytes grown in monolayer (M) were electrophoresed on SDS-
polyacrylamide gels and then Western blotting was performed with anti-HIF-1 antibodies. The blot was re-probed with anti--actin
antibodies as a control for loading. (B) Western analysis for HIF-1 expression in human OA and normal articular chondrocytes cultured in
suspension under normoxic conditions. Lanes 1 and 2, OA chondrocytes; lane 3, normal chondrocytes; lane 4, normal chondrocytes; lanes
5 and 6, OA chondrocytes.
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rabbit polyclonal anti-HIF-1 antibody and the presence of
HIF-1 was revealed with anti-rabbit IgG-biotin and
streptavidin-Texas-red by confocal microscopy. Fig. 4
shows that HIF-1 could be readily detected in the nuclei
of chondrocytes within the normal cartilage sections. A
similar result was obtained when fresh frozen sections
of OA human adult articular cartilage were probed with
anti-HIF-1 antibody (Fig. 5).
REGULATION OF HIF-1 IN OA AND NORMAL CHONDROCYTES BY
TNF-
Pro-inflammatory cytokines, such as TNF-, play a major
role in the pathogenesis of degenerative joint disease.
TNF- has been implicated in the regulation of HIF-1 in
other cell types and has been shown to modulate HIF-1
levels in a non-hypoxia dependent manner23,24. Therefore,
we decided to investigate whether TNF- treatment of
human articular chondrocytes had any effect on the levels
of HIF-1 under normoxic conditions. Fig. 6 shows that
treatment of normal or OA chondrocytes with 10 ng/ml
TNF- for 4 h resulted in an increase in the steady-state
levels of HIF-1. The increase in HIF-1 levels upon
treatment with TNF- was partially abrogated by pretreat-
ment of the cells with either the p38 kinase inhibitor
SB203580 or the NF-B inhibitor pyrrolidine dithio-
carbamate (PDTC). We conclude, therefore, that TNF-
regulates HIF-1 levels in chondrocytes, at least in part,
through NF-B and p38 MAPkinase mediated pathways.
Discussion
The results presented in this study demonstrate for the
first time the expression of HIF-1 and HIF-2 in human
adult articular cartilage. The most important and provoca-
tive finding was that the expression of HIF-1 by cultured
human articular chondrocytes could be readily detected
under normoxic conditions. Furthermore, human articular
chondrocytes that were grown in suspension culture under
ambient O2 levels (21%) to preserve the differentiated
phenotype exhibited an easily detectable level of HIF-1
protein expression as determined by immunoblotting,
whereas chondrocytes that had become de-differentiated
by culture in monolayer did not exhibit detectable HIF-1
expression. When cultured human OA and normal
articular chondrocytes were exposed to hypoxia (1% O2)
for up to 16 h, a modest increase in HIF-1 levels was
observed. In some cases we observed a closely-spaced
set of HIF-1 bands by immunoblotting. A closely spaced
set of bands for HIF-1 has been observed by others and
has been shown to be caused, at least in part, by phos-
phorylation of HIF-1 through the activity of the extracellu-
lar signal reponse kinases (ERKs)37. Interestingly, the
presence of the lower molecular weight HIF-1 bands was
mostly abrogated in articular chondrocytes in response to
increasing duration of exposure to hypoxia. In other cell
types hypoxia has been shown to induce the activity of
ERKs38,39. It remains to be determined whether the
increase in the higher molecular weight HIF-1 bands upon
Fig. 3. Effect of hypoxia on expression of HIF-1 in articular chondrocytes. (A) Calibration of the modular incubation chamber. A dissolved
O2 meter was used to measure the O2 levels in cell culture media after purging the chamber with a mixture of 94% N2, 5% CO2 and 1% O2.
O2 levels are expressed as percent of air saturated media. The chamber was purged at 1 and 8 h for 15 min at a flow rate of 3 l/min (Namiki,
et al.53). (B) Immunofluorescence analysis of HEP 3B cells exposed to 4 h of hypoxia in the modular incubation chamber calibrated in A.
(C–E) Time course of HIF-1 expression in response to hypoxia. OA (panel-C) or normal (panels-D, E) articular chondrocytes cultured in
suspension were incubated in 1% O2 for up to 16 h. Western blot analysis for HIF-1 was performed on nuclear extracts isolated from
chondrocytes at the indicated time points. (F) CoCl2 induction of HIF-1 in normal human articular chondrocytes. Articular chondrocytes
cultured in suspension were treated with 100 µM CoCL2 for 4 h and then nuclear extracts were prepared and subjected to Western blot
analysis with anti-HIF-1 antibody.
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hypoxic treatment of articular chondrocytes was the result
of increased phosphorylation, decreased degradation, or
both. We also demonstrated that treatment of OA and
normal articular chondrocytes with TNF resulted in an
increase in the steady state levels of HIF-1. Pretreatment
of the chondrocyte cultures with inhibitors of p38 MAP
kinase or NF-B partially abrogated the increase in HIF-1
levels in response to TNF.
Articular cartilage, an avascular tissue, derives its oxy-
gen and nutrient supply from the synovial fluid and to some
extent from the underlying subchondral bone, with some of
the chondrocytes in the deepest layers being up to 3–5 mm
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Fig. 4. Localization of HIF-1 in normal cartilage by confocal microscopy. Frozen, fixed, permeabilized and blocked sections of normal
articular cartilage slices were probed with anti-HIF-1 antibodies. HIF-1 localization was revealed with a biotinylated goat anti-rabbit IgG
and streptavidin-Texas red. (A) Alcian blue staining of a serial section (400×). (B) Left panel: Image of lacuna. Right panel: Control section
probed with the biotinylated goat anti-rabbit IgG and streptavidin-Texas red only (600×). (C) Left panel: Image of lacuna. Right panel: Frozen
section probed with anti-HIF-1 antibody (600×). Verification of nuclear staining was achieved by counterstaining with DAPI (not shown).
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Fig. 5. Localization of HIF-1 in OA cartilage by confocal microscopy. Frozen, fixed, permeabilized and blocked sections of OA cartilage
slices were probed with anti-HIF-1 antibodies. HIF-1 localization was revealed with a biotinylated goat anti-rabbit IgG and streptavidin-
Texas red. (A) Alcian blue staining of a serial section (400×). (B) Left panel: Image of lacuna. Right panel: Control section probed with the
biotinylated goat anti-rabbit IgG and streptavidin-Texas red only (600×). (C) Left panel: Image of lacuna. Right panel: Frozen section probed
with anti-HIF-1 antibody (600×). Verification of nuclear staining was achieved by counterstaining with DAPI (not shown).
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Fig. 6. Stimulation of HIF-1 protein levels by TNF- treatment. (A) Normal articular chondrocytes in suspension culture were either not treated, treated with 10 ng/ml TNF- for
4 h or pre-treated with 10 µM of the p38 kinase inhibitor SB203580 for 1 h followed by treatment with 10 ng/ml TNF- for 4 h. Nuclear extracts were then prepared and Western
blot analysis performed with anti-HIF-1 antibodies. (B) OA chondrocytes in suspension culture were either not treated, treated with 10 ng/ml TNF- for 4 h, pre-treated with 10 µM
of the p38 kinase inhibitor SB203580 for 1 h followed by treatment with 10 ng/ml TNF- for 4 h or pretreated with 20 µM of the NF-B inhibitor PDTC for 1 h followed by treatment
with 10 ng/ml TNF- for 4 h. Nuclear extracts were then prepared and Western analysis performed with anti-HIF-1 antibodies.
342
I.B
.Coim
bra
et
al
.:H
IF-1
expression
in
hum
an
articular
chondrocytes
from a supply artery6. This has led to the assumption that
articular cartilage is normally in a hypoxic environment as
compared to vascularized tissues. Measurement of O2
concentrations in synovial fluid and joint tissues along with
in vitro studies support this view1–7,26–29. We observed
HIF-1 expression in chondrocytes cultured in suspension
and in sections of articular cartilage but not in chondrocytes
that had been de-differentiated by monolayer culture con-
ditions. HIF-1 protein expression therefore correlates with
the differentiated chondrocyte phenotype and our results
lend support to the notion that cartilage is generally a
hypoxic tissue. The aggregates and nodules of cartilage-
like tissue that form in the suspension culture system
utilized in the present work may result in a hypoxic environ-
ment thereby triggering the expression of HIF-1 in vitro.
Interestingly, HIF-1 has been found to play a role in
chondrocyte function and survival in the endochondral
growth plate in vivo34. When a targeted deletion of the
HIF-1 gene in the cartilaginous growth plate of mice was
performed, the chondrocytes within the interior of the
growth plate, which are presumed to be hypoxic, under-
went cell death. Furthermore, HIF-1 was found to be
essential for the expression of the glycolytic enzyme phos-
phoglycerate kinase-1 in growth plate chondrocytes, indi-
cating that a decrease in glyocolytic activity may have
contributed to the observed cell death34. A similar role for
HIF-1 in articular chondrocyte metabolism remains to be
established.
Recent investigations have revealed that HIF-1 is regu-
lated by factors other than hypoxia. Of pertinent interest to
the field of chondrocyte biology and arthritis are the findings
that HIF-1 levels and HIF-1 DNA-binding activity can be
modulated by pro-inflammatory cytokines such as IL-1 and
TNF-, and also by growth factors and hormones such as
TGF-, IGF-1 and –2 and insulin. Indeed, HIF-1 was shown
to be involved in the induction of insulin and IGF-
responsive genes including glucose transporter and glyco-
lytic enzyme genes, and VEGF40–42. Even more recent
work has elucidated that the activation of HIF-1 by insulin
and insulin-like growth factors proceeds through a pathway
dependent upon PI-3 kinase and MAP kinase in retinal
epithelial, HepG2 and colon carcinoma cells, a regulatory
mechanism distinct from that of hypoxia21,43,44. However,
in other work, insulin and IGF-1 stabilized HIF-1 in L8
myoblasts in a manner similar to hypoxic regulation40.
Moreover, IGF-2 and IGF-binding proteins 2 and 3 are
HIF-1 target genes implicating HIF-1 in an IGF stimulated
autocrine loop42,45. Although the mechanism of HIF-1 acti-
vation by insulin and IGFs may be different in different
cell types, the implications for articular chondrocytes are
important, especially since IGF-1 and-2 are considered to
be autocrine survival factors for these cells46. Interestingly,
the work herein and other investigations into the regulation
of HIF-1 by cytokines such as IL-1 and TNF- has
revealed that they also cause an induction of HIF-
123,47,48. In support of our findings that induction of HIF-1
in chondrocytes by TNF- is, at least in part, modulated
through NF-B, induction of HIF-1 in NIH3T3 fibroblasts
has also been reported to be mediated through activation of
NF-B23. Similarly, p38 has been implicated in the induc-
tion of HIF-1 expression by thrombin in human vascular
smooth muscle cells49.
We also demonstrated the expression of HIF-2 mRNA
in both normal and OA human articular chondrocytes.
HIF-2 was originally described as an endothelial cell
specific factor, however, more recent results indicate a
more widespread expression pattern35. HIF-2 can activate
some of the same genes as HIF-1, including erythro-
poietin and VEGF, and recent work indeed indicates that
HIF-2 can activate a subset of the genes inducible by
HIF-150. Interestingly, this subset does not include the
glycolytic genes that can be induced by hypoxia through
HIF-150. The functional significance of the HIF-2 mRNA
expression in human articular chondrocytes observed in
this work is currently being investigated.
It is believed that chondrocytes are the source of TNF-
expression found in OA and that chondrocytes respond to
TNF- in a catabolic fashion including the production of
other inflammatory cytokines such as IL-1 and IL-851.
Modulation of the metabolic status of chondrocytes in
response to these cytokines is well established and it is
interesting to speculate that some of this modulation occurs
through a HIF-1 mediated pathway. In support of this
notion, it has been reported that both IL-1 and TNF-
increase glucose transport in human articular chondrocytes
and up-regulate mRNA expression of glucose transporters,
which are HIF-1 target genes52. We are currently trying to
determine the subset of genes that are activated through
HIF-1 by pro-inflammatory cytokines in articular chondro-
cytes. In conclusion, since HIF-1 modulates the activity of
a large number of genes relevant to chondrocyte metab-
olism, growth, survival, and differentiation, the findings
in this work concerning the expression of HIF-1 in articular
chondrocytes and its induction by cytokines has import-
ant implications for its role in the regulation of the
chondrocyte-specific phenotype in both normal and
pathological situations.
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